CN101229312A - Medicine compounds capable of regulating hypertension, hyperlipemia and angina - Google Patents
Medicine compounds capable of regulating hypertension, hyperlipemia and angina Download PDFInfo
- Publication number
- CN101229312A CN101229312A CNA2007100036376A CN200710003637A CN101229312A CN 101229312 A CN101229312 A CN 101229312A CN A2007100036376 A CNA2007100036376 A CN A2007100036376A CN 200710003637 A CN200710003637 A CN 200710003637A CN 101229312 A CN101229312 A CN 101229312A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight
- hypertension
- radix
- weight portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine combination of adjusting hypertension, hyperlipidemia and angina, consisting of astragalus, panax, salvia, cynostemma, americanwater plantain, ginkgo biloba, panax notoginseng, hawthorn, mythic fungus, schisandra, fragrant solomonseal rhizome and wolfberry fruit. The medicine combination of the invention has the advantages of invigorating qi and replenishing yin, activating blood and stabilizing pain, nourishing heart and calming mind, replenishing qi and nourishing blood, supplementing spleen and invigorating kidney, promoting moisture and urination, clearing heat, detoxifying and cooling blood, reducing tension, clearing liver, reducing lipid, nourishing yin, improving eyesight, reinforcing kidney, reducing sugar, dual directionally regulating and etc. Meanwhile, the medicine has an obvious effect on treating hypertension, hyperlipidemia, angina, and the hypertensions and anginas caused by unknown reasons.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of hypertension, hyperlipidemia and anginal pharmaceutical composition of adjusting that have.
Background technology
Hypertension, hyperlipidemia, angina pectoris and myocardial infarction are a kind of commonly encountered diseases, frequently-occurring disease, its serious harm human health, and along with living condition's improvement, the sickness rate of this class disease is more and more higher.General treatment hypertension, hyperlipidemia, angina pectoris or myocardial infarction mainly adopt Western medicine at present, but the Western medicine toxic and side effects is big, and curative effect is single, and cure rate is low.Though also there are some Chinese medicines to be used for the treatment of hypertension, hyperlipidemia, angina pectoris or myocardial infarction, but the traditional Chinese medical science is prevented and treated hypertension, hyperlipidemia, angina pectoris or the sick effect of myocardial infarction is outstanding for many years, the clinical experiment effect is not remarkable, and treatment means is single, so fail to obtain good result yet.
Summary of the invention
The object of the invention is to provide a kind of hypertension, hyperlipidemia and anginal pharmaceutical composition of adjusting that have.
The present invention is achieved through the following technical solutions:
Radix Astragali 15-45 weight portion Radix Panacis Quinquefolii 10-30 weight portion Radix Salviae Miltiorrhizae 15-45 weight portion
Herb Gynostemmae Pentaphylli 10-30 weight portion Rhizoma Alismatis 15-45 weight portion Folium Ginkgo 10-30 weight portion
Radix Notoginseng 10-30 weight portion Fructus Crataegi 10-30 weight portion Ganoderma 10-30 weight portion
Fructus Schisandrae Chinensis 10-30 weight portion Rhizoma Polygonati Odorati 10-30 weight portion Fructus Lycii 10-30 weight portion
The optimum ratio of pharmaceutical composition of the present invention is:
The Radix Astragali 30 weight portion Radix Panacis Quinquefoliis 20 weight portion Radix Salviae Miltiorrhizaes 30 weight portions
Herb Gynostemmae Pentaphylli 20 weight portion Rhizoma Alismatis 30 weight portion Folium Ginkgos 20 weight portions
Radix Notoginseng 20 weight portion Fructus Crataegis 20 weight portion Ganodermas 20 weight portions
Fructus Schisandrae Chinensis 20 weight portion Rhizoma Polygonati Odorati 20 weight portion Fructus Lycii 20 weight portions
The optimum ratio of pharmaceutical composition of the present invention is not
The Radix Astragali 20 weight portion Radix Panacis Quinquefoliis 25 weight portion Radix Salviae Miltiorrhizaes 40 weight portions
Herb Gynostemmae Pentaphylli 15 weight portion Rhizoma Alismatis 20 weight portion Folium Ginkgos 25 weight portions
Radix Notoginseng 15 weight portion Fructus Crataegis 15 weight portion Ganodermas 25 weight portions
Fructus Schisandrae Chinensis 15 weight portion Rhizoma Polygonati Odorati 15 weight portion Fructus Lycii 25 weight portions
The optimum ratio of pharmaceutical composition of the present invention is:
The Radix Astragali 40 weight portion Radix Panacis Quinquefoliis 15 weight portion Radix Salviae Miltiorrhizaes 20 weight portions
Herb Gynostemmae Pentaphylli 25 weight portion Rhizoma Alismatis 40 weight portion Folium Ginkgos 15 weight portions
Radix Notoginseng 25 weight portion Fructus Crataegis 25 weight portion Ganodermas 15 weight portions
Fructus Schisandrae Chinensis 25 weight portion Rhizoma Polygonati Odorati 25 weight portion Fructus Lycii 15 weight portions
The optimum ratio of pharmaceutical composition of the present invention is:
The Radix Astragali 12 weight portion Radix Panacis Quinquefoliis 28 weight portion Radix Salviae Miltiorrhizaes 25 weight portions
Herb Gynostemmae Pentaphylli 28 weight portion Rhizoma Alismatis 25 weight portion Folium Ginkgos 28 weight portions
Radix Notoginseng 12 weight portion Fructus Crataegis 28 weight portion Ganodermas 12 weight portions
Fructus Schisandrae Chinensis 28 weight portion Rhizoma Polygonati Odorati 12 weight portion Fructus Lycii 28 weight portions
The optimum ratio of pharmaceutical composition of the present invention is:
The Radix Astragali 43 weight portion Radix Panacis Quinquefoliis 12 weight portion Radix Salviae Miltiorrhizaes 43 weight portions
Herb Gynostemmae Pentaphylli 12 weight portion Rhizoma Alismatis 43 weight portion Folium Ginkgos 12 weight portions
Radix Notoginseng 28 weight portion Fructus Crataegis 12 weight portion Ganodermas 28 weight portions
Fructus Schisandrae Chinensis 12 weight portion Rhizoma Polygonati Odorati 28 weight portion Fructus Lycii 12 weight portions
Pharmaceutical composition of the present invention adds conventional adjuvant by the dosage form of often making clinical acceptance by practice of pharmacy, as tablet, capsule, granule, pill, powder or oral liquid etc.
Pharmaceutical composition of the present invention has boosting qi and nourishing yin, the analgesic therapy of invigorating blood circulation, tranquilizing by nourishing the heart, benefiting QI and nourishing blood, spleen reinforcing strong kidney, dampness removing diuretic, heat-clearing and toxic substances removing removing heat from blood, blood pressure lowering, liver heat removing, blood fat reducing, YIN nourishing, make eye bright, effects such as kidney tonifying, blood sugar lowering, two-ways regulation, to treatment hypertension, hyperlipidemia, angina pectoris, and the hypertension and the angina pectoris of various unknown causes remarkable result is all arranged.
Following experimental example and embodiment are used to further specify but are not limited to the present invention.
The present invention's " long-acting heart pellet that protects " clinical observation hypertension, hyperlipidemia, patient with angina pectoris 275 people obtain remarkable result, now are reported as follows:
One, clinical observation
Among the 275 routine patients, hypertension wherein, coronary heart disease, hyperlipemia 43 people, brain hypertension lacks property heart disease 52 people, renal hypertension angina pectoris 35 people, lung angina pectoris hypotension 20 people, rheumatic heart disease hypertension angina pectoris 10 people, cerebral ischemia hypertension angina pectoris 6 people, anemia hypotension 15 people, myocardial ischemia heart failure 20 people, cerebral thrombosis 11 people, hypertension cerebral embolism 6 people, acute myocardial infarction 3 people, pulmonary heart disease hyperlipidemia angina pectoris 11 people, cerebral arteriosclerosis hyperlipidemia hypertension angina pectoris 11 people, myocardium coronary arteries sclerosis hypertension, hyperlipemia disease 18 people, general purpura 3 people, paroxysmal hypertension angina pectoris 11 people; Wherein male 132 people, women 143 people; The oldest 75 years old 32,83 of minimum 45 years old of age, 160 of age 50-70 year; The course of disease is the longest 15 years 35, the shortest 5 years 65 of the course of disease, 175 people of course of disease 6-14.
Two, Therapeutic Method
1, medicine is formed: Radix Astragali 30g, Radix Panacis Quinquefolii 20g, Radix Salviae Miltiorrhizae 30g, Herb Gynostemmae Pentaphylli 20g, Rhizoma Alismatis 30g, Folium Ginkgo 20g, Radix Notoginseng 20g, Fructus Crataegi 20g, Ganoderma 20g, Fructus Schisandrae Chinensis 20g, Rhizoma Polygonati Odorati 20g, Fructus Lycii 20g.
2, preparation method: said medicine is pressed practice of pharmacy, and technology adding mountain flower Mel is an amount of routinely, and processed with honey is a ball.The heavy 9g of every ball.
3, instructions of taking: one day 2-3 time, one time one ball, warm water delivery service.
Three, criterion of therapeutical effect
Effectively: take the present invention's " long-acting heart ball that protects " after 10 days the state of an illness alleviate, blood pressure drops, rate and blood-lipid decreased, disease is controlled;
Produce effects: take the present invention's " long-acting heart ball that protects " blood pressure drops after 20 days, rate and blood-lipid decreased, angina pectoris disappears, and symptom subtracts greatly;
Invalid: after taking the present invention's " long-acting heart ball that protects " 3-6 month, all sick improvement of not having.
Four, therapeutic outcome
Hypertension, coronary heart disease and hyperlipemia 43 people, produce effects 38 people, effective 4 people, invalid 1 people; Brain hypertension lacks property heart disease 52 people, produce effects 41 people, effective 5 people, invalid 6 people; Renal hypertension angina pectoris 35 people, produce effects 29 people, effective 6 people; Lung angina pectoris hypotension 20 people, produce effects 14 people, effective 4 people, invalid 2 people; Rheumatic heart disease hypertension angina pectoris 10 people, produce effects 6 people, effective 3 people, invalid 1 people; Cerebral ischemia hypertension angina pectoris 6 people, produce effects 6 people; Anemia hypotension 15 people, produce effects 10 people, effective 4 people, invalid 1 people; Myocardial ischemia heart failure 20 people, produce effects 12 people, effective 6 people, invalid 2 people; Cerebral thrombosis 11 people, produce effects 8 people, effective 3 people; Hypertension cerebral embolism 6 people, produce effects 5 people, effective 1 people; Acute myocardial infarction 3 people, produce effects 3 people; Pulmonary heart disease hyperlipidemia angina pectoris 11 people, produce effects 8 people, effective 2 people, invalid 1 people; Cerebral arteriosclerosis hyperlipidemia hypertension angina pectoris 11 people, produce effects 10 people, effective 1 people; Myocardium coronary arteries sclerosis hypertension, hyperlipemia disease 18 people, produce effects 13 people, effective 4 people, invalid 1 people; General purpura 3 people, produce effects 2 people, effective 1 people; Paroxysmal hypertension angina pectoris 11 people, produce effects 8 people, effective 2 people, invalid 1 people.Total effective rate reaches more than 94%.
Five, model case
Case 1: Wu *, the woman, 48 years old, the Chinese, the Sichuan nationality, certain secretary in charge of something of woollen mill, went to a doctor February 9 calendar year 2001:
Readme: dizzy dizzy, nervous breathing hard, feeling of oppression and pain in the chest, surplus self-induction aggravation near month.The comprehensive analysis of the data gained by the four methods of diagnosis general introduction: found trouble " hypertension " in 85 years, back state of an illness aggravation, once 89 years in certain medical institutions' inspection, electrocardiogram shows " arrhythmia, left ventricle thickens ", in the recent period feeling of oppression and pain in the chest, the general weakness of breathing hard is not thought drink, fidgety dizzy tinnitus yearningly; yellow urine, deficient, constipation, and the food of receiving is poor; insomnia and dreamful sleep, the simple and unadorned color of face, red tongue; matter is deep red, no fur is dry and astringent.Hear: arrhythmia, A2 advances on the right side, and the heart class aorta heart is debated district's audible, inhales the phase tail noise that contracts, and 86/ minute, the wet noise bp190/120mmHg of thin sieve of two base of lung point audibles.Palpation: arteries and veins card drags by force, and the percussion of heart arteries and veins is expanded to left down and moved, atremia, the apex of the heart has impulsion, do not see swollen, liver, palpation of spleen: do not see enlargement and pain.Modern medicine is checked, routine blood test: leukocyte 8300, neutrality 70%, lymph 26.7%, red Archon 4,990 ten thousand mm3H694%.Electrocardio diagram sinus rhythm left ventricular hypertrophy is undesired.The cerebral blood flow diagram: cerebral artery vessel elasticity lowers, examination of ocular fundus: ocular fundus arteriosclerosis, and the rising broadening of Chest X-rays aorta side, left and right ventricle all broadening expansion is attached most importance to left ventricle especially.Tcm diagnosis: dizzy property apoplexy is wind apoplex involving the channels and collaterals and internal organs (doctor trained in Western medicine: the hypertensive heart disease angina pectoris).Disease is analysed: feelings will is hindered, and suffers tremendous loss in strength or resources the resistance of the heart arteries and veins stasis of blood plug stasis of blood, the stagnation of QI, the stagnation of QI and feeling of oppression and pain in the chest, blood failing to tonify the heart is cardiopalmus then, nervous cardiopalmus, palpitation with a distress feeling uneasiness, cardiopathia impairing the lung are dirty, so see short breath, the stagnation of QI, blood stasis, venation is obstructed, cold the change for a long time then gives birth to hot air wind producing, injures liver, then the vertigo, arteries and veins tongue card also is, the resembling of the blood stasis gas stasis of blood.Legislation: blood circulation promoting and blood stasis dispelling, the liver-smoothing, qi-regulating resolving depression, supplementing qi and invigorating vasculum, mind tranquilizing and the heart calming, heat clearing away, the heat that clears away heart-fire of detoxifying is removed liver-heat, and the arresting convulsion spasmolytic is dispeled the wind, the removing heat from blood cooling, antalgic and sedative is had one's ideas straightened out and is refreshed oneself.Took medicine of the present invention 4 months, every day 2-3 time, each 1 ball, look into June 15 calendar year 2001, above-mentioned symptom disappears, and the clothes that continue pill consolidation of the present invention is kept, look in January, 2002, condition of illness disappears and does not send out, and visits also not morbidity again in March, 2003, looks into disease on the 30th in December in 2003 and disappears.On February 20th, 2004 visited, not recurrence.
Case 2: the king *, the man, 60 years old, the Chinese, the Henan nationality, certain repair plant's work, on March 11st, 2002 went to a doctor:
Readme: feeling of oppression and pain in the chest, dysphoria, 2 years surplus, evening insomnia, nervous palpitation and insomnia, stool couple of days once, urine is many.Comprehensive analysis of the data gained by the four methods of diagnosis general introductions: before 3 years suddenly chest pain increase the weight of aggravation, pain after " coronary atherosclerosis heart disease, " is made a definite diagnosis by hospital and give and take medicines such as beniol, linoleic acid, blood pressure lowering be peaceful, did not see after the medication to be clearly better that the spy requires Chinese traditional treatment in nearly six months unbearably.Look into and examine: except that the feeling of oppression and pain in the chest tachypnea is breathed hard, go back poor appetite insomnia, the cardiac muscle weightening finish, xerostomia, gas heat, the prolonged constipation dark coloured urine is in a trance, suspiciously worries too much, lusterless complexion, color is dark, and the eyes color is light black, and early simple and unadorned, color is clear, red tongue, TAIGAN (sic), xanthorrhiza does not have refreshing dry tongue.Heart rate 80/ minute, pulse condition: stringy and tense pulse, height, puckery, liver does not touch, and does not see enlargement, and percussion does not see that the makings sexually transmitted disease (STD) becomes reaction, no ascites.Modern medicine is checked summary: lipid determination, and serum cholesterol 190mg% beta Lipoprotein is 340mg%, the electrocardio diagram: test is positive.Tcm diagnosis: angina pectoris, excessive rising of liver-YANG cause dizzy dizzy sensation of oppression over the chest with shortness of breath, palpitation and insomnia.Doctor trained in Western medicine: coronary atherosclerotic heart disease.Disease is analysed: be resembling of blood-vessel obstructive, and the blood stasis vapour lock, ancient doctor is moving: " stagnation of QI and blood may bring about pain, general rule are not bitterly ".So see feeling of oppression and pain in the chest, arteries and veins is seen puckery, and diseases such as blood stasis vapour lock are not so blood is supported honor, blood failing to nourish tendons, " nail being the surplus of tendons." so see blue or green xerostomia, the strongly fragrant stasis of blood asthma of lip pomade heat.Legislation: blood circulation promoting and blood stasis dispelling, the promoting the circulation of blood blood stasis dispelling, tranquilizing by nourishing the heart, the general solution pain relieving, diuresis, strengthening heart and replenishing qi spleen invigorating Yin-nourishing and body fluid promoting, the refreshment of having one's ideas straightened out are pressed in the removing heat from blood pool.Element culturing fixed folder, kidney tonifying nourishing the liver enriching yin and nourishing kidney, the clear away heart-fire blood pressure lowering control of beneficial heart nourishing blood to tranquillize the mind mind calming, heat-clearing and toxic substances removing removing heat from blood is pained.Debating disease executes and controls: take the present invention's " long-acting two Hu Xindan that fall " (pill) a day 3 times, and 1 time 1 ball, boiled water takes, serve on 6 months, all transference cures, and can all take care of oneself, visit not recurrence in June, 2003, visited also not morbidity in 2004, all are stable.
Following embodiment all can realize the described effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Radix Astragali 30kg Radix Panacis Quinquefolii 20kg Radix Salviae Miltiorrhizae 30kg
Herb Gynostemmae Pentaphylli 20kg Rhizoma Alismatis 30kg Folium Ginkgo 20kg
Radix Notoginseng 20kg Fructus Crataegi 20kg Ganoderma 20kg
Fructus Schisandrae Chinensis 20kg Rhizoma Polygonati Odorati 20kg Fructus Lycii 20kg
Technology adding mountain flower Mel is an amount of routinely for said medicine, and processed with honey is a ball, the heavy 9g of every ball, every day 2-3 time, each ball, warm water delivery service.
Embodiment 2:
Radix Astragali 20kg Radix Panacis Quinquefolii 25kg Radix Salviae Miltiorrhizae 40kg
Herb Gynostemmae Pentaphylli 15kg Rhizoma Alismatis 20kg Folium Ginkgo 25kg
Radix Notoginseng 15kg Fructus Crataegi 15kg Ganoderma 25kg
Fructus Schisandrae Chinensis 15kg Rhizoma Polygonati Odorati 15kg Fructus Lycii 25kg
Said medicine technology routinely adds conventional adjuvant and makes tablet.
Embodiment 3:
Radix Astragali 40kg Radix Panacis Quinquefolii 15kg Radix Salviae Miltiorrhizae 20kg
Herb Gynostemmae Pentaphylli 25kg Rhizoma Alismatis 40kg Folium Ginkgo 15kg
Radix Notoginseng 25kg Fructus Crataegi 25kg Ganoderma 15kg
Fructus Schisandrae Chinensis 25kg Rhizoma Polygonati Odorati 25kg Fructus Lycii 15kg
Said medicine technology routinely adds conventional adjuvant and makes capsule.
Embodiment 4:
Radix Astragali 12kg Radix Panacis Quinquefolii 28kg Radix Salviae Miltiorrhizae 25kg
Herb Gynostemmae Pentaphylli 28kg Rhizoma Alismatis 25kg Folium Ginkgo 28kg
Radix Notoginseng 12kg Fructus Crataegi 28kg Ganoderma 12kg
Fructus Schisandrae Chinensis 28kg Rhizoma Polygonati Odorati 12kg Fructus Lycii 28kg
Said medicine technology routinely adds conventional adjuvant and makes oral liquid.
Embodiment 5:
Radix Astragali 43kg Radix Panacis Quinquefolii 12kg Radix Salviae Miltiorrhizae 43kg
Herb Gynostemmae Pentaphylli 12kg Rhizoma Alismatis 43kg Folium Ginkgo 12kg
Radix Notoginseng 28kg Fructus Crataegi 12kg Ganoderma 28kg
Fructus Schisandrae Chinensis 12kg Rhizoma Polygonati Odorati 28kg Fructus Lycii 12kg
Said medicine technology routinely adds conventional adjuvant and makes granule.
Claims (10)
1. one kind has hypertension, hyperlipidemia and the anginal pharmaceutical composition of adjusting, it is characterized in that the crude drug of this pharmaceutical composition consists of:
Radix Astragali 15-45 weight portion Radix Panacis Quinquefolii 10-30 weight portion Radix Salviae Miltiorrhizae 15-45 weight portion
Herb Gynostemmae Pentaphylli 10-30 weight portion Rhizoma Alismatis 15-45 weight portion Folium Ginkgo 10-30 weight portion
Radix Notoginseng 10-30 weight portion Fructus Crataegi 10-30 weight portion Ganoderma 10-30 weight portion
Fructus Schisandrae Chinensis 10-30 weight portion Rhizoma Polygonati Odorati 10-30 weight portion Fructus Lycii 10-30 weight portion.
2. pharmaceutical composition according to claim 1 is characterized in that the crude drug of said composition consists of:
The Radix Astragali 30 weight portion Radix Panacis Quinquefoliis 20 weight portion Radix Salviae Miltiorrhizaes 30 weight portions
Herb Gynostemmae Pentaphylli 20 weight portion Rhizoma Alismatis 30 weight portion Folium Ginkgos 20 weight portions
Radix Notoginseng 20 weight portion Fructus Crataegis 20 weight portion Ganodermas 20 weight portions
Fructus Schisandrae Chinensis 20 weight portion Rhizoma Polygonati Odorati 20 weight portion Fructus Lycii 20 weight portions.
3. pharmaceutical composition according to claim 1 is characterized in that the crude drug of said composition consists of:
The Radix Astragali 20 weight portion Radix Panacis Quinquefoliis 25 weight portion Radix Salviae Miltiorrhizaes 40 weight portions
Herb Gynostemmae Pentaphylli 15 weight portion Rhizoma Alismatis 20 weight portion Folium Ginkgos 25 weight portions
Radix Notoginseng 15 weight portion Fructus Crataegis 15 weight portion Ganodermas 25 weight portions
Fructus Schisandrae Chinensis 15 weight portion Rhizoma Polygonati Odorati 15 weight portion Fructus Lycii 25 weight portions.
4. pharmaceutical composition according to claim 1 is characterized in that the crude drug of said composition consists of:
The Radix Astragali 40 weight portion Radix Panacis Quinquefoliis 15 weight portion Radix Salviae Miltiorrhizaes 20 weight portions
Herb Gynostemmae Pentaphylli 25 weight portion Rhizoma Alismatis 40 weight portion Folium Ginkgos 15 weight portions
Radix Notoginseng 25 weight portion Fructus Crataegis 25 weight portion Ganodermas 15 weight portions
Fructus Schisandrae Chinensis 25 weight portion Rhizoma Polygonati Odorati 25 weight portion Fructus Lycii 15 weight portions.
5. pharmaceutical composition according to claim 1 is characterized in that the crude drug of said composition consists of:
The Radix Astragali 12 weight portion Radix Panacis Quinquefoliis 28 weight portion Radix Salviae Miltiorrhizaes 25 weight portions
Herb Gynostemmae Pentaphylli 28 weight portion Rhizoma Alismatis 25 weight portion Folium Ginkgos 28 weight portions
Radix Notoginseng 12 weight portion Fructus Crataegis 28 weight portion Ganodermas 12 weight portions
Fructus Schisandrae Chinensis 28 weight portion Rhizoma Polygonati Odorati 12 weight portion Fructus Lycii 28 weight portions.
6. pharmaceutical composition according to claim 1 is characterized in that the crude drug of said composition consists of:
The Radix Astragali 43 weight portion Radix Panacis Quinquefoliis 12 weight portion Radix Salviae Miltiorrhizaes 43 weight portions
Herb Gynostemmae Pentaphylli 12 weight portion Rhizoma Alismatis 43 weight portion Folium Ginkgos 12 weight portions
Radix Notoginseng 28 weight portion Fructus Crataegis 12 weight portion Ganodermas 28 weight portions
Fructus Schisandrae Chinensis 12 weight portion Rhizoma Polygonati Odorati 28 weight portion Fructus Lycii 12 weight portions.
7. according to the described pharmaceutical composition of one of claim 1-6, it is characterized in that this pharmaceutical composition adds conventional adjuvant is made clinical acceptance according to common process dosage form by practice of pharmacy.
8. the dosage form of pharmaceutical composition according to claim 7 is characterized in that described dosage form is tablet, capsule, granule, pill, powder or oral liquid.
9. has application in the medicine of regulating hypertension, angina pectoris, hypotension, hyperlipidemia, cerebral thrombosis, myocardial ischemia and myocardial infarction according to the described pharmaceutical composition of one of claim 1-6 in preparation.
10. application according to claim 9 is characterized in that described hypertension and angina pectoris are meant that brain hypertension lacks property heart disease, renal hypertension angina pectoris, the angina pectoris of rheumatic heart disease hypertension, the angina pectoris of cerebral ischemia hypertension, hypertension cerebral embolism, the angina pectoris of pulmonary heart disease hyperlipidemia, lung angina pectoris hypotension, the angina pectoris of cerebral arteriosclerosis hyperlipidemia hypertension, myocardium coronary arteries sclerosis hypertension, hyperlipemia disease, general purpura and paroxysmal hypertension angina pectoris; Described hypotension is meant the anemia hypotension; Described myocardial ischemia is meant the myocardial ischemia heart failure; Described myocardial infarction is meant acute myocardial infarction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100036376A CN101229312A (en) | 2007-01-23 | 2007-01-23 | Medicine compounds capable of regulating hypertension, hyperlipemia and angina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100036376A CN101229312A (en) | 2007-01-23 | 2007-01-23 | Medicine compounds capable of regulating hypertension, hyperlipemia and angina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101229312A true CN101229312A (en) | 2008-07-30 |
Family
ID=39896325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100036376A Pending CN101229312A (en) | 2007-01-23 | 2007-01-23 | Medicine compounds capable of regulating hypertension, hyperlipemia and angina |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101229312A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804110A (en) * | 2010-05-05 | 2010-08-18 | 杨勤峰 | Traditional Chinese medicine preparation for purifying blood |
| CN101953918A (en) * | 2010-10-13 | 2011-01-26 | 南方医科大学 | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| CN101966288A (en) * | 2009-07-28 | 2011-02-09 | 李松民 | Blood pressure-reduction tea |
| CN101461896B (en) * | 2009-01-12 | 2012-05-16 | 东方药林药业有限公司 | Chinese medicinal composition assistant for reducing blood fat and preparation method thereof |
| CN103041070A (en) * | 2012-12-31 | 2013-04-17 | 青岛华仁信息技术开发有限公司 | Lipid-lowering and pressure-releasing folium ginkgo health-care product and preparation method thereof |
| CN103055159A (en) * | 2013-01-30 | 2013-04-24 | 梁鸿健 | Medicine for treating hypertension |
| CN103142696A (en) * | 2013-03-08 | 2013-06-12 | 潘恩山 | Vessel-invigorating and life-prolonging soup and preparation method thereof |
| CN103223107A (en) * | 2013-03-27 | 2013-07-31 | 熊建珍 | Traditional Chinese medicine used for adjusting blood fat and blood pressure, and preparation technology thereof |
| CN103948791A (en) * | 2014-03-28 | 2014-07-30 | 河北御芝林药业有限公司 | Traditional Chinese medicinal composition for reducing blood fat, and preparation method thereof |
| CN104645205A (en) * | 2015-03-11 | 2015-05-27 | 成都坤七健康咨询有限公司 | Traditional Chinese medicine effective part composition for treating hyperlipidemia and preparation method of composition |
| CN104906399A (en) * | 2015-06-16 | 2015-09-16 | 郭前进 | Traditional Chinese medicine pills for treating heart disease and preparation method of traditional Chinese medicine pills |
| CN105267488A (en) * | 2014-12-26 | 2016-01-27 | 完美（中国）有限公司 | Traditional Chinese medicine composition capable of assisting to reduce blood fat and protect liver and products thereof |
| CN105410508A (en) * | 2014-09-05 | 2016-03-23 | 深圳华大基因研究院 | Health food and preparation method thereof |
| CN109172703A (en) * | 2018-08-01 | 2019-01-11 | 姚代军 | Special doctor's food of lower hyperlipidemia, hypertension, hyperglycemia and the preparation method and application thereof |
| CN109793867A (en) * | 2017-11-14 | 2019-05-24 | 仝二法 | Blood fat-reducing blood pressure-decreasing medicinal herb tea |
-
2007
- 2007-01-23 CN CNA2007100036376A patent/CN101229312A/en active Pending
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461896B (en) * | 2009-01-12 | 2012-05-16 | 东方药林药业有限公司 | Chinese medicinal composition assistant for reducing blood fat and preparation method thereof |
| CN101966288A (en) * | 2009-07-28 | 2011-02-09 | 李松民 | Blood pressure-reduction tea |
| CN101804110A (en) * | 2010-05-05 | 2010-08-18 | 杨勤峰 | Traditional Chinese medicine preparation for purifying blood |
| CN101953918A (en) * | 2010-10-13 | 2011-01-26 | 南方医科大学 | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| CN103041070B (en) * | 2012-12-31 | 2014-11-05 | 青岛华仁技术孵化器有限公司 | Lipid-lowering and pressure-releasing folium ginkgo health-care product and preparation method thereof |
| CN103041070A (en) * | 2012-12-31 | 2013-04-17 | 青岛华仁信息技术开发有限公司 | Lipid-lowering and pressure-releasing folium ginkgo health-care product and preparation method thereof |
| CN103055159A (en) * | 2013-01-30 | 2013-04-24 | 梁鸿健 | Medicine for treating hypertension |
| CN103055159B (en) * | 2013-01-30 | 2014-06-25 | 梁鸿健 | Medicine for treating hypertension |
| CN103142696A (en) * | 2013-03-08 | 2013-06-12 | 潘恩山 | Vessel-invigorating and life-prolonging soup and preparation method thereof |
| CN103142696B (en) * | 2013-03-08 | 2015-04-22 | 潘恩山 | Vessel-invigorating and life-prolonging soup and preparation method thereof |
| CN103223107A (en) * | 2013-03-27 | 2013-07-31 | 熊建珍 | Traditional Chinese medicine used for adjusting blood fat and blood pressure, and preparation technology thereof |
| CN103948791B (en) * | 2014-03-28 | 2019-11-12 | 河北御芝林药业有限公司 | A kind of Chinese medicine composition of reducing blood lipid and preparation method thereof |
| CN103948791A (en) * | 2014-03-28 | 2014-07-30 | 河北御芝林药业有限公司 | Traditional Chinese medicinal composition for reducing blood fat, and preparation method thereof |
| CN105410508A (en) * | 2014-09-05 | 2016-03-23 | 深圳华大基因研究院 | Health food and preparation method thereof |
| CN105267488A (en) * | 2014-12-26 | 2016-01-27 | 完美（中国）有限公司 | Traditional Chinese medicine composition capable of assisting to reduce blood fat and protect liver and products thereof |
| CN104645205A (en) * | 2015-03-11 | 2015-05-27 | 成都坤七健康咨询有限公司 | Traditional Chinese medicine effective part composition for treating hyperlipidemia and preparation method of composition |
| CN104906399A (en) * | 2015-06-16 | 2015-09-16 | 郭前进 | Traditional Chinese medicine pills for treating heart disease and preparation method of traditional Chinese medicine pills |
| CN104906399B (en) * | 2015-06-16 | 2018-05-04 | 郭前进 | One kind treats cardiopathic medicine pill and preparation method thereof |
| CN109793867A (en) * | 2017-11-14 | 2019-05-24 | 仝二法 | Blood fat-reducing blood pressure-decreasing medicinal herb tea |
| CN109793867B (en) * | 2017-11-14 | 2022-07-05 | 仝二法 | Lipid-lowering and pressure-lowering medicinal tea |
| CN109172703A (en) * | 2018-08-01 | 2019-01-11 | 姚代军 | Special doctor's food of lower hyperlipidemia, hypertension, hyperglycemia and the preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101229312A (en) | Medicine compounds capable of regulating hypertension, hyperlipemia and angina | |
| CN101991816B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
| CN101524469B (en) | Chinese herbal medicine compound preparation for treating congestive heart failure and preparation method thereof | |
| CN103202879B (en) | Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof | |
| CN103372135B (en) | Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance | |
| CN101721608B (en) | Chinese herbal medicine pill used for treating heart diseases | |
| CN103316144B (en) | Chinese medicine composition capable of invigorating qi and blood, nourishing yin and yang, improving immunity, resisting to fatigue and inhibiting thrombogenesis | |
| CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
| CN102406799A (en) | Cataplasm paste for treating diabetes and hypertension complicated with coronary heart disease and preparation method thereof | |
| CN102343049B (en) | Chinese medicinal capsules for treating hypertension due to liver-yang hyperactivity | |
| CN100574800C (en) | A kind of Chinese patent medicine for the treatment of atherosclerosis of cardio-cerebral arteria and preparation method thereof | |
| CN106177759B (en) | A kind of compound Chinese medicinal preparation and its preparation process for treating coronary disease and angina pectoris | |
| CN105055967B (en) | A kind of complex health care product and preparation method with auxiliary hyperglycemic function | |
| CN103041327A (en) | Traditional Chinese medicine for treating sick sinus syndrome single nucleotide and preparation method thereof | |
| CN105833055A (en) | Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia and preparing method and application thereof | |
| CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN110882347A (en) | A Chinese medicinal composition for treating cardiovascular diseases | |
| CN100415262C (en) | Medicine for treating cerebral infraction and its preparing method | |
| CN114796420B (en) | Traditional Chinese medicine composition for treating non-valvular atrial fibrillation as well as traditional Chinese medicine preparation and application thereof | |
| CN108126101A (en) | It is a kind of to be used to treat pharmaceutical preparation of diabetic cardiomyopathy and preparation method thereof | |
| CN114848775B (en) | Traditional Chinese medicine composition for treating acute myocardial infarction as well as traditional Chinese medicine preparation and application thereof | |
| CN102670718A (en) | Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method of same | |
| CN101366910B (en) | Traditional Chinese medicine for treating frequent premature beat | |
| CN105535454A (en) | Medicine for treating diastolic cardiac dysfunction | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080730 |